Loading...
Portfolio Diversification
Range
Most Diversified
31 instruments
August 19, 2025
Least Diversified
0 instruments
February 1, 2022
Average
29.3 instruments
Most Consistent Holdings
Top 5
JNJ97.74%
MRK97.74%
PFE97.74%
AMGN97.74%
ABBV97.74%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since February 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Bridgebio (BBIO) | 4.11% | 3.8% | 77.03% | - |
 Guardant Health (GH) | 3.86% | 5.19% | 97.74% | - |
 Eli Lilly (LLY) | 3.8% | 3.48% | 97.74% | - |
 Exact Sciences (EXAS) | 3.47% | 3.78% | 97.74% | - |
 Vertex (VRTX) | 3.43% | 0% | 96.12% | 12/29/2025 |
 Gilead Sciences (GILD) | 3.27% | 3.38% | 97.74% | - |
| Merck (MRK) | 3.22% | 3.28% | 97.74% | - |
| Johnson & Johnson (JNJ) | 3.21% | 3.29% | 97.74% | - |
| AbbVie (ABBV) | 3.14% | 2.92% | 97.74% | - |
| Amgen (AMGN) | 3.11% | 2.95% | 97.74% | - |
 Regeneron (REGN) | 3.11% | 3.15% | 97.46% | - |
 Illumina (ILMN) | 2.96% | 3.1% | 97.6% | - |
 Bristol-Myers Squibb (BMY) | 2.95% | 2.92% | 97.53% | - |
| Pfizer (PFE) | 2.88% | 3.3% | 97.74% | - |
 ImmunoGen Inc (IMGN) | 2.82% | 0% | 48.27% | 2/14/2024 |
 Exelixis (EXEL) | 2.68% | 2.63% | 72.66% | - |
 Revolution Medicines (RVMD) | 2.59% | 5.51% | 77.03% | - |
 Argenx (ARGX) | 2.49% | 3.01% | 76.74% | - |
 CRISPR Therapeutics (CRSP) | 2.46% | 0% | 70.4% | 12/26/2024 |
 Syndax (SNDX) | 2.27% | 3.6% | 77.03% | - |
 Blueprint Medicines (BPMC) | 2.14% | 0% | 64.41% | 7/23/2025 |
 Iovance (IOVA) | 2.12% | 0% | 75.33% | 12/29/2025 |
 Arcellx (ACLX) | 1.86% | 3.45% | 52.5% | - |
 AstraZeneca (AZN) | 1.65% | 2.77% | 52.5% | - |
 TG Therapeutics (TGTX) | 1.64% | 0% | 46.51% | 12/29/2025 |
 Mirati Therapeutics Inc (MRTX) | 1.43% | 0% | 47.29% | 1/31/2024 |
 Zai Lab (ZLAB) | 1.37% | 0% | 50.11% | 12/29/2025 |
 SpringWorks Therapeutics (SWTX) | 1.36% | 0% | 38.48% | 7/3/2025 |
 BD (BDX) | 1.35% | 0% | 50.88% | 12/29/2025 |
 BeiGene (ONC) | 1.3% | 3.02% | 46.86% | - |
 Crinetics (CRNX) | 1.28% | 0% | 34.32% | 12/29/2025 |
 Fate Therapeutics (FATE) | 1.12% | 0% | 45.24% | 1/2/2024 |
 Seagen Inc (SGEN) | 1.05% | 0% | 23.47% | 12/18/2023 |
 Merus (MRUS) | 1.02% | 0% | 26.29% | 1/6/2026 |
 Halozyme (HALO) | 0.97% | 2.9% | 27.34% | - |
 Scholar Rock (SRRK) | 0.88% | 4.13% | 27.34% | - |
 Legend Biotech (LEGN) | 0.86% | 0% | 24.52% | 1/2/2024 |
 Incyte (INCY) | 0.85% | 0% | 20.72% | 1/12/2023 |
 BioNTech SE (BNTX) | 0.79% | 0% | 20.72% | 1/12/2023 |
 2Seventy Bio (TSVT) | 0.78% | 0% | 20.72% | 1/12/2023 |
 Option Care Health (OPCH) | 0.77% | 0% | 25.16% | 12/26/2024 |
 Rocket (RCKT) | 0.71% | 0% | 25.16% | 12/26/2024 |
 Arvinas (ARVN) | 0.71% | 0% | 25.16% | 12/26/2024 |
 Agenus (AGEN) | 0.7% | 0% | 20.72% | 1/12/2023 |
 LabCorp (LH) | 0.69% | 0% | 20.72% | 1/12/2023 |
 GlaxoSmithKline (GSK) | 0.64% | 0% | 20.72% | 1/12/2023 |
 MannKind (MNKD) | 0.64% | 0% | 24.52% | 1/2/2024 |
 Celldex (CLDX) | 0.58% | 2.6% | 26.15% | - |
 Sorrento (SRNE) | 0.56% | 0% | 20.72% | 1/12/2023 |
 Inovio (INO) | 0.53% | 0% | 20.72% | 1/12/2023 |
 Clovis Oncology Inc (CLVSQ) | 0.47% | 0% | 19.31% | 12/22/2022 |
 Janux (JANX) | 0.44% | 0% | 25.72% | 12/29/2025 |
 Surface Oncology Inc (SURF) | 0.35% | 0% | 19.31% | 12/22/2022 |
 Invitae Corp (NVTAQ) | 0.26% | 0% | 20.72% | 1/12/2023 |
 Curis (CRIS) | 0.24% | 0% | 19.31% | 12/22/2022 |
 IDEAYA (IDYA) | 0.23% | 3.09% | 10.57% | - |
 Novocure (NVCR) | 0.21% | 0% | 9.09% | 12/29/2025 |
 Olema (OLMA) | 0.06% | 3.92% | 1.62% | - |
 Cogent Biosciences (COGT) | 0.05% | 3.65% | 1.62% | - |
 Nuvalent (NUVL) | 0.05% | 3.16% | 1.62% | - |
 Arcus Biosciences (RCUS) | 0.04% | 2.61% | 1.62% | - |
 Zymeworks (ZYME) | 0.04% | 2.35% | 1.62% | - |
 Kura Oncology (KURA) | 0.03% | 2.84% | 1.06% | - |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2026
| Instrument | Invested | Value |
|---|---|---|
| Guardant Health (GH) | 1.68% | 4.75% |
| Scholar Rock (SRRK) | 5.61% | 4.2% |
| Revolution Medicines (RVMD) | 1.73% | 3.89% |
| Bridgebio (BBIO) | 0.53% | 3.88% |
| Exact Sciences (EXAS) | 3.33% | 3.86% |
| Syndax (SNDX) | 5.26% | 3.85% |
| Olema (OLMA) | 5.06% | 3.77% |
| Eli Lilly (LLY) | 1.72% | 3.7% |
| Gilead Sciences (GILD) | 2.61% | 3.45% |
| Regeneron (REGN) | 3.95% | 3.42% |
| Cogent Biosciences (COGT) | 4.73% | 3.34% |
| Pfizer (PFE) | 5.63% | 3.31% |
| Merck (MRK) | 3.82% | 3.26% |
| AbbVie (ABBV) | 2.93% | 3.24% |
| Argenx (ARGX) | 2.09% | 3.22% |
| Johnson & Johnson (JNJ) | 3.36% | 3.22% |
| Arcellx (ACLX) | 3.82% | 3.21% |
| Merus (MRUS) | 1.93% | 3.1% |
| IDEAYA (IDYA) | 3.24% | 3.08% |
| Nuvalent (NUVL) | 4.1% | 3.08% |
| Amgen (AMGN) | 2.99% | 3.01% |
| Bristol-Myers Squibb (BMY) | 4.34% | 3% |
| AstraZeneca (AZN) | 2.82% | 2.92% |
| Arcus Biosciences (RCUS) | 3.66% | 2.91% |
| Celldex (CLDX) | 3.62% | 2.9% |
| Halozyme (HALO) | 2.65% | 2.85% |
| Illumina (ILMN) | 3.04% | 2.84% |
| BeiGene (ONC) | 3.75% | 2.82% |
| Exelixis (EXEL) | 1.82% | 2.71% |
| Zymeworks (ZYME) | 3.52% | 2.7% |
Cash & Instruments Over Time
Unlock Premium Features
Get access to this feature and many more with BullAware Pro.